Clinical Trials Logo

Clinical Trial Summary

The main purpose of this study is to describe the pattern of RIF consumption in real life conditions, whatever the reasons of initiation and the chosen formula. The main objective is to study the reasons for prescribing a RIF during the first year of life, as per the pediatrician. Consumption started before 6 months of age, when milk and infantile formulas predominates in the baby's feeding, is of particular interest.


Clinical Trial Description

The main purpose of this study is to describe the pattern of RIF consumption in real life conditions, whatever the reasons of initiation and the chosen formula. The main objective is to study the reasons for prescribing a RIF during the first year of life, as per the pediatrician. Consumption started before 6 months of age, when milk and infantile formulas predominates in the baby's feeding, is of particular interest. Secondary objectives are to describe the modalities of feeding before, during and after consuming the RIF, to describe the growth of children who have consumed a RIF for at least 1 month, on the basis of anthropometric data collected during the first year of life. As a second intention, this study also aims to monitor the evolution of child's digestive and allergic symptoms, if any, and the sociodemographic characteristics of the infant's family. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06318117
Study type Observational
Source Mead Johnson Nutrition
Contact Amy Benson, MS
Phone 8124298905
Email amy.benson@reckitt.com
Status Not yet recruiting
Phase
Start date March 30, 2024
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT05578716 - Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula N/A
Completed NCT00340665 - Study of Infant Diets on Estrogen Activity and Development
Completed NCT05224947 - Gastric Layering and Monitoring II N/A
Completed NCT01625273 - Supplementation of Infant Formula With Synbiotics N/A
Completed NCT05097924 - Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns
Recruiting NCT05992493 - The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term Infants
Completed NCT03456934 - Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease N/A
Recruiting NCT05868408 - Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants N/A
Completed NCT05295030 - Effects of Breast Milk Simulated Infant Formula N/A